Related Experiment Video
Updated: Aug 11, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Vancomycin-induced linear IgA bullous dermatosis: morphology is a key to diagnosis
Benjamin A Solky1, Laura Pincus, Richard F Horan
1Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA. bsolky@partners.org
Insights
Vancomycin can cause linear IgA bullous dermatosis (LABD). A specific presentation of grouped, annular vesicles strongly suggests vancomycin-induced LABD, aiding early diagnosis and antibiotic management.
Area of Science:
- Dermatology
- Pharmacology
- Immunology
Background:
- Linear IgA bullous dermatosis (LABD) is a rare autoimmune blistering disease.
- Previous reports indicate vancomycin-induced LABD often lacks specific clinical features.
Observation:
- This case highlights a patient with vancomycin-induced LABD presenting with distinct, annularly arranged vesicles.
- This specific morphology is proposed as a key diagnostic clue.
Findings:
- The annular vesicular pattern in this patient strongly suggests drug-induced LABD.
- Vancomycin was identified as the likely causative agent based on the clinical presentation.
Implications:
- Clinicians should consider vancomycin-induced LABD when encountering this specific annular vesicular morphology.
- Early suspicion can guide antibiotic selection and patient management while awaiting definitive diagnosis.
Abstract:
Vancomycin-induced linear IgA bullous dermatosis (LABD) previously has been described; however, past reports have suggested that the clinical presentation is nonspecific. We present a case of vancomycin-induced LABD with a suggestive clinical presentation; specifically, groups of annularly arranged vesicles. We propose that this clinical presentation strongly suggests drug-induced LABD and should raise a clinician's suspicion of vancomycin as the offending agent. This awareness may guide the antibiotic management of the patient while the clinician awaits histopathologic correlation.
Related Concept Videos
Immunocytochemistry and Immunohistochemistry
These...
Inflammatory Bowel Disease II: Ulcerative Colitis

